124 related articles for article (PubMed ID: 22999923)
1. R280T mutation of p53 gene promotes proliferation of human glioma cells through GSK-3β/PTEN pathway.
Lin C; Liang Y; Zhu H; Zhang J; Zhong X
Neurosci Lett; 2012 Oct; 529(1):60-5. PubMed ID: 22999923
[TBL] [Abstract][Full Text] [Related]
2. 14-3-3β regulates the proliferation of glioma cells through the GSK3β/β-catenin signaling pathway.
Gong F; Wang G; Ye J; Li T; Bai H; Wang W
Oncol Rep; 2013 Dec; 30(6):2976-82. PubMed ID: 24065186
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms underlying effects of epidermal growth factor receptor inhibition on invasion, proliferation, and angiogenesis in experimental glioma.
Guillamo JS; de Boüard S; Valable S; Marteau L; Leuraud P; Marie Y; Poupon MF; Parienti JJ; Raymond E; Peschanski M
Clin Cancer Res; 2009 Jun; 15(11):3697-704. PubMed ID: 19435839
[TBL] [Abstract][Full Text] [Related]
4. Essential role of Notch signaling in apoptosis of human pancreatic tumoral cells mediated by exosomal nanoparticles.
Ristorcelli E; Beraud E; Mathieu S; Lombardo D; Verine A
Int J Cancer; 2009 Sep; 125(5):1016-26. PubMed ID: 19405120
[TBL] [Abstract][Full Text] [Related]
5. Regulation of SHP2 by PTEN/AKT/GSK-3β signaling facilitates IFN-γ resistance in hyperproliferating gastric cancer.
Tseng PC; Huang WC; Chen CL; Sheu BS; Shan YS; Tsai CC; Wang CY; Chen SO; Hsieh CY; Lin CF
Immunobiology; 2012 Sep; 217(9):926-34. PubMed ID: 22325465
[TBL] [Abstract][Full Text] [Related]
6. Heterozygous p53-R280T Mutation Enhances the Oncogenicity of NPC Cells Through Activating PI3K-Akt Signaling Pathway.
Qin ZQ; Li QG; Yi H; Lu SS; Huang W; Rong ZX; Tang YY; Xiao ZQ
Front Oncol; 2020; 10():104. PubMed ID: 32117754
[TBL] [Abstract][Full Text] [Related]
7. PTEN differentially regulates expressions of ICAM-1 and VCAM-1 through PI3K/Akt/GSK-3β/GATA-6 signaling pathways in TNF-α-activated human endothelial cells.
Tsoyi K; Jang HJ; Nizamutdinova IT; Park K; Kim YM; Kim HJ; Seo HG; Lee JH; Chang KC
Atherosclerosis; 2010 Nov; 213(1):115-21. PubMed ID: 20864106
[TBL] [Abstract][Full Text] [Related]
8. PTEN regulation by the Akt/GSK-3β axis during RANKL signaling.
Jang HD; Noh JY; Shin JH; Lin JJ; Lee SY
Bone; 2013 Jul; 55(1):126-31. PubMed ID: 23419777
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinases-3beta controls differentiation of malignant glioma cells.
Li Y; Lu H; Huang Y; Xiao R; Cai X; He S; Yan G
Int J Cancer; 2010 Sep; 127(6):1271-82. PubMed ID: 19882709
[TBL] [Abstract][Full Text] [Related]
10. GSK3β/β-catenin signaling is correlated with the differentiation of glioma cells induced by wogonin.
Wang Y; Zhang Y; Qian C; Cai M; Li Y; Li Z; You Q; Wang Q; Hu R; Guo Q
Toxicol Lett; 2013 Oct; 222(2):212-23. PubMed ID: 23872260
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells.
Tan J; Zhuang L; Leong HS; Iyer NG; Liu ET; Yu Q
Cancer Res; 2005 Oct; 65(19):9012-20. PubMed ID: 16204075
[TBL] [Abstract][Full Text] [Related]
12. SIRT1 promotes proliferation and inhibits apoptosis of human malignant glioma cell lines.
Qu Y; Zhang J; Wu S; Li B; Liu S; Cheng J
Neurosci Lett; 2012 Sep; 525(2):168-72. PubMed ID: 22867969
[TBL] [Abstract][Full Text] [Related]
13. Role of PTEN in cholera toxin-induced SWO‑38 glioma cell differentiation.
Wang MH; Lin CL; Zhang JJ; Weng ZP; Hu T; Xie Q; Zhong XY
Mol Med Rep; 2013 Jun; 7(6):1912-8. PubMed ID: 23595342
[TBL] [Abstract][Full Text] [Related]
14. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
[TBL] [Abstract][Full Text] [Related]
15. Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas.
Atkins RJ; Dimou J; Paradiso L; Morokoff AP; Kaye AH; Drummond KJ; Hovens CM
J Clin Neurosci; 2012 Nov; 19(11):1558-63. PubMed ID: 22999562
[TBL] [Abstract][Full Text] [Related]
16. The glycogen synthase kinase (GSK) 3beta represses RNA polymerase I transcription.
Vincent T; Kukalev A; Andäng M; Pettersson R; Percipalle P
Oncogene; 2008 Sep; 27(39):5254-9. PubMed ID: 18490923
[TBL] [Abstract][Full Text] [Related]
17. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
18. S100A4 negatively regulates β-catenin by inducing the Egr-1-PTEN-Akt-GSK3β degradation pathway.
Yang W; Nam K; Ju JH; Lee KM; Oh S; Shin I
Cell Signal; 2014 Oct; 26(10):2096-106. PubMed ID: 24975844
[TBL] [Abstract][Full Text] [Related]
19. The PTEN/Akt pathway dictates the direct alphaVbeta3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo.
Kawaguchi T; Yamashita Y; Kanamori M; Endersby R; Bankiewicz KS; Baker SJ; Bergers G; Pieper RO
Cancer Res; 2006 Dec; 66(23):11331-40. PubMed ID: 17145879
[TBL] [Abstract][Full Text] [Related]
20. Role of DJ-1-induced PTEN down-regulation in migration and invasion of human glioma cells.
Fang M; Zhong XY; Du B; Lin CL; Luo F; Tang LJ; Chen J
Chin J Cancer; 2010 Dec; 29(12):988-94. PubMed ID: 21114918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
